Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers
- PMID: 15269712
- DOI: 10.1038/sj.gt.3302312
Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers
Abstract
Nonviral gene delivery systems based on conventional high-molecular-weight chitosans are efficient after lung administration in vivo, but have poor physical properties such as aggregated shapes, low solubility at neutral pH, high viscosity at concentrations used for in vivo delivery and a slow dissociation and release of plasmid DNA, resulting in a slow onset of action. We therefore developed highly effective nonviral gene delivery systems with improved physical properties from a series of chitosan oligomers, ranging in molecular weight from 1.2 to 10 kDa. First, we established structure-property relationships with regard to polyplex formation and in vivo efficiency after lung administration to mice. In a second step, we isolated chitosan oligomers from a preferred oligomer fraction to obtain fractions, ranging from 10 to 50-mers, of more homogeneous size distributions with polydispersities ranging from 1.01 to 1.09. Polyplexes based on chitosan oligomers dissociated more easily than those of a high-molecular-weight ultrapure chitosan (UPC, approximately a 1000-mer), and released pDNA in the presence of anionic heparin. The more easily dissociated polyplexes mediated a faster onset of action and gave a higher gene expression both in 293 cells in vitro and after lung administration in vivo as compared to the more stable UPC polyplexes. Already 24 h after intratracheal administration, a 120- to 260-fold higher luciferase gene expression was observed compared to UPC in the mouse lung in vivo. The gene expression in the lung was comparable to that of PEI (respective AUCs of 2756+/-710 and 3320+/-871 pg luciferase x days/mg of total lung protein). In conclusion, a major improvement of chitosan-mediated nonviral gene delivery to the lung was obtained by using polyplexes of well-defined chitosan oligomers. Polyplexes of oligomer fractions also had superior physicochemical properties to commonly used high-molecular-weight UPC.
Similar articles
-
Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo.Gene Ther. 2001 Jul;8(14):1108-21. doi: 10.1038/sj.gt.3301492. Gene Ther. 2001. PMID: 11526458
-
Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo.J Gene Med. 2003 Feb;5(2):130-41. doi: 10.1002/jgm.327. J Gene Med. 2003. PMID: 12539151
-
Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo.J Control Release. 2006 Sep 28;115(1):103-12. doi: 10.1016/j.jconrel.2006.06.029. Epub 2006 Jul 1. J Control Release. 2006. PMID: 16901570
-
Targeted polymers for gene delivery.Expert Opin Drug Deliv. 2005 Jan;2(1):145-57. doi: 10.1517/17425247.2.1.145. Expert Opin Drug Deliv. 2005. PMID: 16296741 Review.
-
Chitosan-based formulations for delivery of DNA and siRNA.Adv Drug Deliv Rev. 2010 Jan 31;62(1):12-27. doi: 10.1016/j.addr.2009.08.004. Epub 2009 Sep 29. Adv Drug Deliv Rev. 2010. PMID: 19796660 Review.
Cited by
-
Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy.Int J Nanomedicine. 2018 Feb 8;13:857-875. doi: 10.2147/IJN.S147747. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29467575 Free PMC article.
-
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy.Nat Commun. 2024 Jan 4;15(1):255. doi: 10.1038/s41467-023-44572-6. Nat Commun. 2024. PMID: 38177179 Free PMC article.
-
Chitosan nanoparticles for oral drug and gene delivery.Int J Nanomedicine. 2006;1(2):117-28. doi: 10.2147/nano.2006.1.2.117. Int J Nanomedicine. 2006. PMID: 17722528 Free PMC article. Review.
-
Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer.Mol Cancer Ther. 2014 Jan;13(1):71-81. doi: 10.1158/1535-7163.MCT-13-0502. Epub 2013 Nov 12. Mol Cancer Ther. 2014. PMID: 24222663 Free PMC article.
-
Biodegradable poly(2-dimethylamino ethylamino)phosphazene for in vivo gene delivery to tumor cells. Effect of polymer molecular weight.Pharm Res. 2007 Aug;24(8):1572-80. doi: 10.1007/s11095-007-9299-z. Epub 2007 Apr 11. Pharm Res. 2007. PMID: 17435970 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous